Prostaglandin E2 transactivates EGF receptor:: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

被引:714
作者
Pai, R
Soreghan, B
Szabo, IL
Pavelka, M
Baatar, D
Tarnawski, AS [1 ]
机构
[1] Dept Vet Affairs Med Ctr, Med Serv, Long Beach, CA USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA
关键词
D O I
10.1038/nm0302-289
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostaglandins (PGs), bioactive lipid molecules produced by cyclooxygenase enzymes (COX-1 and COX-2), have diverse biological activities, including growth-promoting actions on gastrointestinal mucosa(1-5). They are also implicated in the growth of colonic polyps and cancers(6). However, the precise mechanisms of these trophic actions of PGs remain unclear. As activation of the epidermal growth factor receptor (EGFR) triggers mitogenic signaling in gastrointestinal mucosa, and its expression is also upregulated in colonic cancers and most neoplasms(7-9), we investigated whether PGs transactivate EGFR. Here we provide evidence that prostaglandin E-2 (PGE(2)) rapidly phosphorylates EGFR and triggers the extracellular signal-regulated kinase 2 (ERK2)-mitogenic signaling pathway in normal gastric epithelial (RGM1) and colon cancer (Caco-2, LoVo and HT-29) cell lines. Inactivation of EGFR kinase with selective inhibitors significantly reduces PGE(2)-induced ERK2 activation, c-fos mRNA expression and cell proliferation. Inhibition of matrix metalloproteinases (MMPs), transforming growth factor-alpha (TGF-alpha) or c-Src blocked PGE(2)-mediated EGFR transactivation and downstream signaling indicating that PGE(2)-induced EGFR transactivation involves signaling transduced via TGF-alpha, an EGFR ligand, likely released by c-Src-activated MMP(s). Our findings that PGE(2) transactivates EGFR reveal a previously unknown mechanism by which PGE(2) mediates trophic actions resulting in gastric and intestinal hypertrophy as well as growth of colonic polyps and cancers.
引用
收藏
页码:289 / 293
页数:5
相关论文
共 27 条
[1]  
Barnes CJ, 1999, CANCER EPIDEM BIOMAR, V8, P311
[2]   Monoclonal antibodies directed at growth factor receptors [J].
Baselga, J .
ANNALS OF ONCOLOGY, 2000, 11 :187-190
[3]   Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and-9 in fetal rat hepatocytes [J].
Callejas, NA ;
Casado, M ;
Díaz-Guerra, MJM ;
Boscá, L ;
Martín-Sanz, P .
HEPATOLOGY, 2001, 33 (04) :860-867
[4]   EFFECTS OF E-SERIE, F-SERIE, AND I-SERIE PROSTAGLANDINS AND ANALOGS ON GROWTH OF GASTRODUODENAL MUCOSA AND PANCREAS [J].
DEMBINSKI, A ;
KONTUREK, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (02) :G170-G175
[5]   Cyclooxygenase, NSAIDs, and colorectal cancer [J].
DuBois, RN ;
Smalley, WE .
JOURNAL OF GASTROENTEROLOGY, 1996, 31 (06) :898-906
[6]   Activation of MAPKs by angiotensin II in vascular smooth muscle cells - Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK [J].
Eguchi, S ;
Dempsey, PJ ;
Frank, GD ;
Motley, ED ;
Inagami, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (11) :7957-7962
[7]   Epidermal growth factor receptors: critical mediators of multiple receptor pathways [J].
Hackel, PO ;
Zwick, E ;
Prenzel, N ;
Ullrich, A .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) :184-189
[8]  
JOHANSSON C, 1983, ADV PROSTAG THROMB L, V12, P403
[9]  
JOHANSSON C, 1982, SCAND J GASTROENTERO, V17, P21
[10]   Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells [J].
Kinoshita, T ;
Takahashi, Y ;
Sakashita, T ;
Inoue, H ;
Tanabe, T ;
Yoshimoto, T .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1999, 1438 (01) :120-130